This Viewpoint discusses steps to implement to effectively address the opioid public health emergency.
This Viewpoint discusses issues associated with the use of pharmacogenetic tests to guide treatment in patients with major depressive disorder.
This randomized clinical trial evaluates the efficacy of dialectical behavior therapy compared with individual and group supportive therapy for reducing suicide attempts, nonsuicidal self-injury, and overall self-harm among high-risk youths.
This randomized clinical trial characterizes the metabolic effects of first exposure to antipsychotics in youths with disruptive behavior disorders using criterion standard assessments of body composition and tissue-specific insulin sensitivity.
This systematic review and meta-analysis examines brain activation response to rewards in individuals with autism spectrum disorder compared with typically developing individuals.
This systemic review and meta-analysis examines the association between hypertensive disorders of pregnancy and risk of neurodevelopmental disorders in offspring.
This national longitudinal cohort study of US adults who had experienced a nonfatal opioid overdose determines rates of all-cause and cause-specific mortality and standardized mortality rate ratios in the first year after the overdose.
This study of a large cohort of Danish women examines the association between first-trimester first abortion or first childbirth with risk of a first-time prescription for an antidepressant.
This longitudinal study compares trajectories of depressive symptoms from ages 10 to 18 years for children with or without autism spectrum disorders and autistic traits and explores the role of genetic confounding and environmental intermediaries such as bullying.
This population-based cohort study characterizes neurocognitive functions in 7-year-old children at familial high risk of schizophrenia and bipolar disorder in the Danish High Risk and Resilience Study VIA 7.
This population-based longitudinal study examined the construct validity and psychometric properties of a measure of psychoticlike symptoms, the Prodromal Questionnaire–Brief Child Version, among children enrolled in the first wave of the Adolescent Brain and Cognitive Development study.
This study assesses data from the 2002 to 2016 US National Survey on Drug Use and Health data sets to determine the percentage of newly incident heroin users who became heroin dependent.
This cohort study investigates year-to-year associations between cannabis use and psychosis over 4 years in youth aged 13 to 16 years.